LifeStance Health (LFST) Equity Average (2020 - 2026)

LifeStance Health (LFST) has 7 years of Equity Average data on file, last reported at $1.5 billion in Q1 2026.

• Equity Average for Q1 2026 came in at $1.5 billion, up 3.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 3.27% YoY), and the FY2025 annual result was $1.5 billion, up 3.2% from the prior year.
• Equity Average declined to $1.5 billion in Q1 2026 per LFST's latest filing, from $1.5 billion in the prior quarter.
• Over five years, Equity Average peaked at $1.5 billion in Q1 2022 and troughed at $1.4 billion in Q1 2024.
• A 5-year average of $1.5 billion and a median of $1.5 billion in 2025 frame the typical range for Equity Average.
• The sharpest annual moves came in 2022 and 2024: Equity Average surged 58.19% in 2022, then retreated 5.49% in 2024.
• A 5-year view of Equity Average shows it stood at $1.5 billion in 2022, then retreated by 5.45% to $1.4 billion in 2023, then decreased by 0.02% to $1.4 billion in 2024, then increased by 4.52% to $1.5 billion in 2025, then fell by 0.51% to $1.5 billion in 2026.
• Business Quant data shows LFST's Equity Average at $1.5 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.5 billion in Q3 2025.